Nanoparticles for cancer imaging

The good, the bad, and the promise

Sandra Chapman, Marina Dobrovolskaia, Keyvan Farahani, Andrew Goodwin, Amit Joshi, Hakho Lee, Thomas Meade, Martin Gilbert Pomper, Krzysztof Ptak, Jianghong Rao, Ravi Singh, Srinivas Sridhar, Stephan Stern, Andrew Wang, John B. Weaver, Gayle Woloschak, Lily Yang

Research output: Contribution to journalArticle

Abstract

Recent advances in molecular imaging and nanotechnology are providing new opportunities for biomedical imaging with great promise for the development of novel imaging agents. The unique optical, magnetic, and chemical properties of materials at the scale of nanometers allow the creation of imaging probes with better contrast enhancement, increased sensitivity, controlled biodistribution, better spatial and temporal information, multi-functionality and multi-modal imaging across MRI, PET, SPECT, and ultrasound. These features could ultimately translate to clinical advantages such as earlier detection, real time assessment of disease progression and personalized medicine. However, several years of investigation into the application of these materials to cancer research has revealed challenges that have delayed the successful application of these agents to the field of biomedical imaging. Understanding these challenges is critical to take full advantage of the benefits offered by nano-sized imaging agents. Therefore, this article presents the lessons learned and challenges encountered by a group of leading researchers in this field, and suggests ways forward to develop nanoparticle probes for cancer imaging.

Original languageEnglish (US)
Pages (from-to)454-460
Number of pages7
JournalNano Today
Volume8
Issue number5
DOIs
StatePublished - Oct 2013

Fingerprint

Nanoparticles
Imaging techniques
Precision Medicine
Nanotechnology
Molecular Imaging
Single-Photon Emission-Computed Tomography
Disease Progression
Neoplasms
Research Personnel
Research
Molecular imaging
Magnetic resonance imaging
Chemical properties
Medicine
Magnetic properties
Optical properties
Ultrasonics

Keywords

  • Cancer
  • Detection
  • Imaging
  • Nanomedicine
  • Screening

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Biomedical Engineering
  • Materials Science(all)
  • Medicine (miscellaneous)
  • Pharmaceutical Science

Cite this

Chapman, S., Dobrovolskaia, M., Farahani, K., Goodwin, A., Joshi, A., Lee, H., ... Yang, L. (2013). Nanoparticles for cancer imaging: The good, the bad, and the promise. Nano Today, 8(5), 454-460. https://doi.org/10.1016/j.nantod.2013.06.001

Nanoparticles for cancer imaging : The good, the bad, and the promise. / Chapman, Sandra; Dobrovolskaia, Marina; Farahani, Keyvan; Goodwin, Andrew; Joshi, Amit; Lee, Hakho; Meade, Thomas; Pomper, Martin Gilbert; Ptak, Krzysztof; Rao, Jianghong; Singh, Ravi; Sridhar, Srinivas; Stern, Stephan; Wang, Andrew; Weaver, John B.; Woloschak, Gayle; Yang, Lily.

In: Nano Today, Vol. 8, No. 5, 10.2013, p. 454-460.

Research output: Contribution to journalArticle

Chapman, S, Dobrovolskaia, M, Farahani, K, Goodwin, A, Joshi, A, Lee, H, Meade, T, Pomper, MG, Ptak, K, Rao, J, Singh, R, Sridhar, S, Stern, S, Wang, A, Weaver, JB, Woloschak, G & Yang, L 2013, 'Nanoparticles for cancer imaging: The good, the bad, and the promise', Nano Today, vol. 8, no. 5, pp. 454-460. https://doi.org/10.1016/j.nantod.2013.06.001
Chapman S, Dobrovolskaia M, Farahani K, Goodwin A, Joshi A, Lee H et al. Nanoparticles for cancer imaging: The good, the bad, and the promise. Nano Today. 2013 Oct;8(5):454-460. https://doi.org/10.1016/j.nantod.2013.06.001
Chapman, Sandra ; Dobrovolskaia, Marina ; Farahani, Keyvan ; Goodwin, Andrew ; Joshi, Amit ; Lee, Hakho ; Meade, Thomas ; Pomper, Martin Gilbert ; Ptak, Krzysztof ; Rao, Jianghong ; Singh, Ravi ; Sridhar, Srinivas ; Stern, Stephan ; Wang, Andrew ; Weaver, John B. ; Woloschak, Gayle ; Yang, Lily. / Nanoparticles for cancer imaging : The good, the bad, and the promise. In: Nano Today. 2013 ; Vol. 8, No. 5. pp. 454-460.
@article{afa00f1601fb4f42a9f6b923bd31b356,
title = "Nanoparticles for cancer imaging: The good, the bad, and the promise",
abstract = "Recent advances in molecular imaging and nanotechnology are providing new opportunities for biomedical imaging with great promise for the development of novel imaging agents. The unique optical, magnetic, and chemical properties of materials at the scale of nanometers allow the creation of imaging probes with better contrast enhancement, increased sensitivity, controlled biodistribution, better spatial and temporal information, multi-functionality and multi-modal imaging across MRI, PET, SPECT, and ultrasound. These features could ultimately translate to clinical advantages such as earlier detection, real time assessment of disease progression and personalized medicine. However, several years of investigation into the application of these materials to cancer research has revealed challenges that have delayed the successful application of these agents to the field of biomedical imaging. Understanding these challenges is critical to take full advantage of the benefits offered by nano-sized imaging agents. Therefore, this article presents the lessons learned and challenges encountered by a group of leading researchers in this field, and suggests ways forward to develop nanoparticle probes for cancer imaging.",
keywords = "Cancer, Detection, Imaging, Nanomedicine, Screening",
author = "Sandra Chapman and Marina Dobrovolskaia and Keyvan Farahani and Andrew Goodwin and Amit Joshi and Hakho Lee and Thomas Meade and Pomper, {Martin Gilbert} and Krzysztof Ptak and Jianghong Rao and Ravi Singh and Srinivas Sridhar and Stephan Stern and Andrew Wang and Weaver, {John B.} and Gayle Woloschak and Lily Yang",
year = "2013",
month = "10",
doi = "10.1016/j.nantod.2013.06.001",
language = "English (US)",
volume = "8",
pages = "454--460",
journal = "Nano Today",
issn = "1748-0132",
publisher = "Elsevier",
number = "5",

}

TY - JOUR

T1 - Nanoparticles for cancer imaging

T2 - The good, the bad, and the promise

AU - Chapman, Sandra

AU - Dobrovolskaia, Marina

AU - Farahani, Keyvan

AU - Goodwin, Andrew

AU - Joshi, Amit

AU - Lee, Hakho

AU - Meade, Thomas

AU - Pomper, Martin Gilbert

AU - Ptak, Krzysztof

AU - Rao, Jianghong

AU - Singh, Ravi

AU - Sridhar, Srinivas

AU - Stern, Stephan

AU - Wang, Andrew

AU - Weaver, John B.

AU - Woloschak, Gayle

AU - Yang, Lily

PY - 2013/10

Y1 - 2013/10

N2 - Recent advances in molecular imaging and nanotechnology are providing new opportunities for biomedical imaging with great promise for the development of novel imaging agents. The unique optical, magnetic, and chemical properties of materials at the scale of nanometers allow the creation of imaging probes with better contrast enhancement, increased sensitivity, controlled biodistribution, better spatial and temporal information, multi-functionality and multi-modal imaging across MRI, PET, SPECT, and ultrasound. These features could ultimately translate to clinical advantages such as earlier detection, real time assessment of disease progression and personalized medicine. However, several years of investigation into the application of these materials to cancer research has revealed challenges that have delayed the successful application of these agents to the field of biomedical imaging. Understanding these challenges is critical to take full advantage of the benefits offered by nano-sized imaging agents. Therefore, this article presents the lessons learned and challenges encountered by a group of leading researchers in this field, and suggests ways forward to develop nanoparticle probes for cancer imaging.

AB - Recent advances in molecular imaging and nanotechnology are providing new opportunities for biomedical imaging with great promise for the development of novel imaging agents. The unique optical, magnetic, and chemical properties of materials at the scale of nanometers allow the creation of imaging probes with better contrast enhancement, increased sensitivity, controlled biodistribution, better spatial and temporal information, multi-functionality and multi-modal imaging across MRI, PET, SPECT, and ultrasound. These features could ultimately translate to clinical advantages such as earlier detection, real time assessment of disease progression and personalized medicine. However, several years of investigation into the application of these materials to cancer research has revealed challenges that have delayed the successful application of these agents to the field of biomedical imaging. Understanding these challenges is critical to take full advantage of the benefits offered by nano-sized imaging agents. Therefore, this article presents the lessons learned and challenges encountered by a group of leading researchers in this field, and suggests ways forward to develop nanoparticle probes for cancer imaging.

KW - Cancer

KW - Detection

KW - Imaging

KW - Nanomedicine

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=84886947107&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886947107&partnerID=8YFLogxK

U2 - 10.1016/j.nantod.2013.06.001

DO - 10.1016/j.nantod.2013.06.001

M3 - Article

VL - 8

SP - 454

EP - 460

JO - Nano Today

JF - Nano Today

SN - 1748-0132

IS - 5

ER -